{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T14:57:09Z","timestamp":1785769029836,"version":"3.56.0"},"reference-count":51,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T00:00:00Z","timestamp":1670284800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"Introduction<\/jats:title>Pneumocystis<\/jats:italic> is a ubiquitous fungal pathogen that causes pneumonia (PCP) and pulmonary sequelae in HIV-infected individuals and other immunocompromised populations. With the success of anti-retroviral therapy for HIV-infected individuals the frequency of PCP in that population has decreased, however, PCP remains a significant cause of morbidity and mortality in individuals with hematologic and solid malignancies, and in individuals treated with immunosuppressive therapies for autoimmune diseases, and following bone marrow and solid organ transplantation. Despite the clinical need, there is no approved vaccine to prevent PCP in vulnerable populations. The ultimate goal of the field is to develop an effective vaccine that can overcome immune deficits in at risk populations and induce long-lasting protective immunity to Pneumocystis<\/jats:italic>. Toward this goal, our laboratory has established a model of PCP co-infection in simian immunodeficiency virus (SIV)-infected non-human primates (NHP) and identified a recombinant protein sub-unit vaccine, KEX1, that induces robust anti-Pneumocystis<\/jats:italic> immunity in immune-competent macaques that is durable and prevents PCP following simian immunodeficiency virus (SIV)-induced immunosuppression. Type I, or invariant natural killer T (iNKT) cells have the potential to provide B cell help under conditions of reduced CD4+ T cell help.<\/jats:p><\/jats:sec>Methods<\/jats:title>In the present study, we used the SIV model of HIV infection to address whether therapeutic vaccination with the iNKT cell-activating adjuvant \u03b1-galactosylceramide (\u03b1-GC) and KEX1 (\u03b1-GC+KEX1) can effectively boost anti-Pneumocystis<\/jats:italic> humoral immunity following virus-induced immunosuppression.<\/jats:p><\/jats:sec>Results<\/jats:title>Immunization of antigen-experienced NHPs with \u03b1-GC+KEX1 during the early chronic phase of SIV-infection significantly boosted anti-Pneumocystis<\/jats:italic> humoral immunity by increasing memory B cells and antibody titers, and enhanced titer durability during SIV-induced immunosuppression. This therapeutic vaccination strategy boosted anti-Pneumocystis<\/jats:italic> immune responses during SIV-infection and contributed to protection against Pneumocystis<\/jats:italic> co-infection in KEX1-vaccinated macaques.<\/jats:p><\/jats:sec>Conclusion<\/jats:title>These studies present a novel strategy for stimulating durable anti-Pneumocystis<\/jats:italic> humoral immunity in the context of complex, chronic SIV-induced immunosuppression and may be further applied to immunization of other immunosuppressed populations, and toward other common recall antigens.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fimmu.2022.1036658","type":"journal-article","created":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T06:19:24Z","timestamp":1670307564000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":13,"title":["A therapeutic vaccine strategy to prevent Pneumocystis pneumonia in an immunocompromised host in a non-human primate model of HIV and Pneumocystis co-infection"],"prefix":"10.3389","volume":"13","author":[{"given":"Whitney","family":"Rabacal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Finja","family":"Schweitzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather M.","family":"Kling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lizabeth","family":"Buzzelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Rayens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen A.","family":"Norris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,12,6]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1086\/591701","article-title":"Relationship of Pneumocystis antibody response to severity of chronic obstructive pulmonary disease","volume":"47","author":"Morris","year":"2008","journal-title":"Clin Infect Dis"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1136\/bmjresp-2020-000842","article-title":"Relationship of Pneumocystis antibody responses to paediatric asthma severity","volume":"8","author":"Rayens","year":"2021","journal-title":"BMJ Open Respir Res"},{"key":"B3","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1016\/j.jaci.2017.09.018","article-title":"Lower airway microbiota and mycobiota in children with severe asthma","volume":"141","author":"Goldman","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jinf.2016.05.001","article-title":"Increased prevalence of Pneumocystis jirovecii colonisation in acute pulmonary exacerbations of cystic fibrosis","volume":"73","author":"Green","year":"2016","journal-title":"J Infect"},{"key":"B5","doi-asserted-by":"publisher","first-page":"S5","DOI":"10.1086\/313843","article-title":"Epidemiology of human immunodeficiency virus-associated opportunistic infections in the united states in the era of highly active antiretroviral therapy","author":"Kaplan","year":"2000","journal-title":"Clin Infect Dis"},{"key":"B6","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1128\/cmr.00013-12","article-title":"Colonization by Pneumocystis jirovecii and its role in disease","volume":"25","author":"Morris","year":"2012","journal-title":"Clin Microbiol Rev"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1086\/515127","article-title":"Editorial response: Prophylaxis for Pneumocystis carinii pneumonia in solid organ transplant recipients\u2013as long as the pros outweigh the cons","volume":"28","author":"Arend","year":"1999","journal-title":"Clin Infect Dis"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/s1053-2498(98)00038-2","article-title":"Recurrent Pneumocystis carinii colonization in a heart-lung transplant recipient on long-term trimethoprim-sulfamethoxazole prophylaxis","volume":"18","author":"Faul","year":"1999","journal-title":"J Heart Lung Transplant"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.163.4.402","article-title":"Trimethoprim-sulfamethoxazole revisited","volume":"163","author":"Masters","year":"2003","journal-title":"Arch Internal Med"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.162.2.9912058","article-title":"Permanent declines in pulmonary function following pneumonia in human immunodeficiency virus-infected persons. the pulmonary complications of HIV infection study group","volume":"162","author":"Morris","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.01712-09","article-title":"Airway obstruction is increased in Pneumocystis-colonized human immunodeficiency virus-infected outpatients","volume":"47","author":"Morris","year":"2009","journal-title":"J Clin Microbiol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1093\/infdis\/161.2.296","article-title":"Serologic responses to Pneumocystis carinii antigens in health and disease","volume":"161","author":"Peglow","year":"1990","journal-title":"J Infect Dis"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-0691.2004.00974.x","article-title":"High seroprevalence of Pneumocystis infection in Spanish children","volume":"10","author":"Respaldiza","year":"2004","journal-title":"Clin Microbiol Infect"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1086\/319340","article-title":"Search for primary infection by Pneumocystis carinii in a cohort of normal, healthy infants","volume":"32","author":"Vargas","year":"2001","journal-title":"Clin Infect Dis"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2010.07.003","article-title":"Seroepidemiological study of Pneumocystis jirovecii infection in healthy infants in Chile using recombinant fragments of the p. jirovecii major surface glycoprotein","volume":"14","author":"Djawe","year":"2010","journal-title":"Int J Infect Dis"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200401-094OC","article-title":"Association of chronic obstructive pulmonary disease severity and Pneumocystis colonization","volume":"170","author":"Morris","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.00507-10","article-title":"Relationship of Pneumocystis jiroveci humoral immunity to prevention of colonization and chronic obstructive pulmonary disease in a primate model of HIV infection","volume":"78","author":"Kling","year":"2010","journal-title":"Infect Immun"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1086\/653485","article-title":"Persistent Pneumocystis colonization leads to the development of chronic obstructive pulmonary disease in a nonhuman primate model of AIDS","volume":"202","author":"Shipley","year":"2010","journal-title":"J Infect Dis"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiw032","article-title":"Vaccine-induced immunogenicity and protection against Pneumocystis pneumonia in a nonhuman primate model of HIV and Pneumocystis coinfection","volume":"213","author":"Kling","year":"2016","journal-title":"J Infect Dis"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0b013e3182167516","article-title":"Serologic responses to Pneumocystis proteins in HIV patients with and without Pneumocystis jirovecii pneumonia","volume":"57","author":"Gingo","year":"2011","journal-title":"J Acquir Immune Defic Syndr"},{"key":"B21","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1146\/annurev.immunol.25.022106.141711","article-title":"The biology of NKT cells","volume":"25","author":"Bendelac","year":"2007","journal-title":"Annu Rev Immunol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2015.00226","article-title":"The response of CD1d-restricted invariant NKT cells to microbial pathogens and their products","volume":"6","author":"Van Kaer","year":"2015","journal-title":"Front Immunol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/nri1531","article-title":"Alpha-galactosylceramide therapy for autoimmune diseases: Prospects and obstacles","volume":"5","author":"Van Kaer","year":"2005","journal-title":"Nat Rev Immunol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1615\/CritRevImmunol.2021040076","article-title":"Natural killer T lymphocytes integrate innate sensory information and relay context to effector immune responses","volume":"41","author":"Joyce","year":"2021","journal-title":"Crit Rev Immunol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20021616","article-title":"CD1d-restricted help to b cells by human invariant natural killer T lymphocytes","volume":"197","author":"Galli","year":"2003","journal-title":"J Exp Med"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0700191104","article-title":"Invariant NKT cells sustain specific b cell responses and memory","volume":"104","author":"Galli","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1303218110","article-title":"(NKT)-b-cell interactions promote prolonged antibody responses and long-term memory to pneumococcal capsular polysaccharides","volume":"110","author":"Bai","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B28","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/ni.2172","article-title":"Invariant natural killer T cells direct b cell responses to cognate lipid antigen in an IL-21-dependent manner","volume":"13","author":"King","year":"2011","journal-title":"Nat Immunol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1504790112","article-title":"Cognate interaction with iNKT cells expands IL-10-producing b regulatory cells","volume":"112","author":"Vomhof-DeKrey","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1701026","article-title":"Memory follicular helper invariant NKT cells recognize lipid antigens on memory b cells and elicit antibody recall responses","volume":"200","author":"Chen","year":"2018","journal-title":"J Immunol"},{"key":"B31","article-title":"The national academies collection: Reports funded by national institutes of health","volume-title":"Guide for the care and use of laboratory animals","year":"2011"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2019.1631135","article-title":"Immunization with Pneumocystis recombinant KEX1 induces robust and durable humoral responses in immunocompromised non-human primates","volume":"15","author":"Cobos Jim\u00e9nez","year":"2019","journal-title":"Hum Vaccin Immunother"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1038\/321435a0","article-title":"Isolation of an HTLV-III-related retrovirus from macaques with simian AIDS and its possible origin in asymptomatic mangabeys","volume":"321","author":"Murphey-Corb","year":"1986","journal-title":"Nature."},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1177\/030098588802500609","article-title":"Necropsy findings in rhesus monkeys experimentally infected with cultured simian immunodeficiency virus (SIV)\/delta","volume":"25","author":"Baskin","year":"1988","journal-title":"Vet Pathol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.30802\/aalas-cm-18-000012","article-title":"Longitudinal evaluation of pulmonary arterial hypertension in a rhesus macaque (Macaca mulatta) model of HIV infection","volume":"68","author":"Tarantelli","year":"2018","journal-title":"Comp Med"},{"key":"B36","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1089\/aid.2018.0132","article-title":"Monocyte and alveolar macrophage skewing is associated with the development of pulmonary arterial hypertension in a primate model of HIV infection","volume":"35","author":"Schweitzer","year":"2019","journal-title":"AIDS Res Hum Retroviruses"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1086\/373997","article-title":"Experimental Pneumocystis carinii pneumonia in simian immunodeficiency virus-infected rhesus macaques","volume":"187","author":"Board","year":"2003","journal-title":"J Infect Dis"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1084\/jem.187.6.875","article-title":"Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes","volume":"187","author":"Sallusto","year":"1998","journal-title":"J Exp Med"},{"key":"B39","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1086\/595297","article-title":"Pneumocystis colonization in immunocompetent and simian immunodeficiency virus-infected cynomolgus macaques","volume":"199","author":"Kling","year":"2009","journal-title":"J Infect Dis"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1093\/labmed\/27.8.547","article-title":"Detecting Pneumocystis carinii by immunohistochemistry","volume":"27","author":"Nayar","year":"1996","journal-title":"Lab Med"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1002928","article-title":"Loss of effector and anti-inflammatory natural killer T lymphocyte function in pathogenic simian immunodeficiency virus infection","volume":"8","author":"Rout","year":"2012","journal-title":"PloS Pathog"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1586\/erv.10.132","article-title":"Cytolytic CD4(+) T cells in viral immunity","volume":"9","author":"Soghoian","year":"2010","journal-title":"Expert Rev Vaccines"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1086\/429298","article-title":"Compromised b cell responses to influenza vaccination in HIV-infected individuals","volume":"191","author":"Malaspina","year":"2005","journal-title":"J Infect Dis"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2893.2005.00658.x","article-title":"Response to hepatitis a vaccine in HIV-positive patients1","volume":"13","author":"Weissman","year":"2006","journal-title":"J Viral Hepatitis"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2013.07.008","article-title":"Subnormal and waning immunity to tetanus toxoid in previously vaccinated HIV-infected children and response to booster doses of the vaccine","volume":"17","author":"Choudhury","year":"2013","journal-title":"Int J Infect Dis"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.178.12.8212","article-title":"Loss of discrete memory b cell subsets is associated with impaired immunization responses in HIV-1 infection and may be a risk factor for invasive pneumococcal disease","volume":"178","author":"Hart","year":"2007","journal-title":"J Immunol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-06-166249","article-title":"NKT-cell help to b lymphocytes can occur independently of cognate interaction","volume":"113","author":"Tonti","year":"2009","journal-title":"Blood."},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1016\/j.coi.2014.01.007","article-title":"Invariant NKT cells provide innate and adaptive help for b cells","volume":"28","author":"Vomhof-DeKrey","year":"2014","journal-title":"Curr Opin Immunol"},{"key":"B49","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/ni.2166","article-title":"Identification of bcl-6-dependent follicular helper NKT cells that provide cognate help for b cell responses","volume":"13","author":"Chang","year":"2011","journal-title":"Nat Immunol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1103501","article-title":"Follicular helper NKT cells induce limited b cell responses and germinal center formation in the absence of CD4(+) T cell help","volume":"188","author":"Tonti","year":"2012","journal-title":"J Immunol"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1038\/nchembio.1650","article-title":"A semisynthetic carbohydrate-lipid vaccine that protects against s. pneumoniae in mice","volume":"10","author":"Cavallari","year":"2014","journal-title":"Nat Chem Biol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.1036658\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T06:19:28Z","timestamp":1670307568000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.1036658\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,6]]},"references-count":51,"alternative-id":["10.3389\/fimmu.2022.1036658"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2022.1036658","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,6]]},"article-number":"1036658"}}